Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Donald J. Piegors"'
Autor:
Donald D. Heistad, Francis J. Miller, Steven R. Lentz, José A. Fernández, Rochelle A. Erger, John H. Griffin, Donald J. Piegors
Publikováno v:
Circulation. 106:842-846
Background— Diet-induced atherosclerosis in monkeys produces abnormal anticoagulant responses to thrombin, including decreased generation of activated protein C (APC). We tested the hypothesis that anticoagulant responses to thrombin increase towar
Publikováno v:
Circulation Research. 90:277-283
Superoxide (O 2 ·− ) in arteries may contribute to atherosclerosis in part by inactivation of nitric oxide. We hypothesized that regression of atherosclerosis in nonhuman primates is associated with a decrease in vascular NAD(P)H oxidase, decrease
Publikováno v:
Circulation. 103:1006-1011
Background —Hyperhomocysteinemia is associated with increased risk of atherosclerotic and thrombotic vascular disease. In many patients, hyperhomocysteinemia can be treated or prevented by dietary supplementation with B vitamins, but the clinical b
Autor:
Donald J. Piegors, M Y Bhopatkar, Christopher G. Sobey, Steven R. Lentz, Donald D. Heistad, Frank M. Faraci, M R Malinow
Publikováno v:
Journal of Clinical Investigation. 98:24-29
Elevated plasma homocyst(e)ine may predispose to complications of vascular disease. Homocysteine alters vasomotor regulatory and anticoagulant properties of cultured vascular endothelial cells, but little is known about effects of hyperhomocyst(e)ine
Autor:
Donald J. Piegors, Andreas Mügge, Mark L. Armstrong, Peter Densen, Donald D. Heistad, J.Antonio G. Lopez, Richard C. Padgett
Publikováno v:
Atherosclerosis. 95:211-222
Activated leukocytes release a variety of substances which have been shown in vitro to modulate vascular tone. The chemotactic peptide complement C5a is a physiological activator of leukocytes. We injected human recombinant complement C5a (10 and 100
Autor:
John H. Griffin, Nigel S. Key, Arne Slungaard, Donald J. Piegors, Janel R. Long, José A. Fernández, Steven R. Lentz
Publikováno v:
Blood. 102(1)
Platelet factor 4 (PF4), an abundant platelet α-granule protein, accelerates in vitro generation of activated protein C (APC) by soluble thrombin/thrombomodulin (TM) complexes up to 25-fold. To test the hypothesis that PF4 similarly stimulates endot
Autor:
Donald D. Heistad, John H. Griffin, William G. Haynes, Erland Arning, M. Rene Malinow, José A. Fernández, Steven R. Lentz, Rochelle A. Erger, Teodoro Bottiglieri, Donald J. Piegors
Publikováno v:
Blood. 100(6)
Hyperhomocysteinemia has been proposed to inhibit the protein C anticoagulant system through 2 mechanisms: decreased generation of activated protein C (APC) by thrombin, and resistance to APC caused by decreased inactivation of factor Va (FVa). We te
Autor:
José A. Fernández, Donald D. Heistad, M R Malinow, Donald J. Piegors, Steven R. Lentz, Rochelle A. Erger, John H. Griffin
Publikováno v:
Arteriosclerosis, thrombosis, and vascular biology. 19(7)
Abstract —To examine the effects of atherosclerosis on the protein C anticoagulant pathway in vivo, we measured anticoagulant responses to intravenous administration of human α-thrombin or activated protein C (APC) in cynomolgus monkeys. Two group
Autor:
Frank M. Faraci, Donald D. Heistad, Steven R. Lentz, M Bhopatkar-Teredesai, Donald J. Piegors, M R Malinow
Publikováno v:
Arteriosclerosis, thrombosis, and vascular biology. 17(11)
Abstract Moderate elevation of plasma homocyst(e)ine is associated with increased risk for atherosclerotic vascular disease. In a previous study, we observed impaired vascular function in nonatherosclerotic monkeys with moderate hyperhomocyst(e)inemi
Publikováno v:
Stroke. 27(5)
Background and Purpose This study tested the hypothesis that functional abnormalities of carotid and ocular arteries may improve after short-term regression of atherosclerosis, before regression of structural abnormalities. Methods We examined effect